These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32631973)

  • 21. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis.
    Wilmer MJ; Christensen EI; van den Heuvel LP; Monnens LA; Levtchenko EN
    Am J Kidney Dis; 2008 Jun; 51(6):893-903. PubMed ID: 18455850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML; Olgaard K; Lewin E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.
    van Husen M; Lehnhardt A; Fischer AK; Brinkert F; Loos S; Oh J; Kemper MJ
    Pediatr Transplant; 2012 Aug; 16(5):443-50. PubMed ID: 22554017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis.
    Cheung WW; Cherqui S; Ding W; Esparza M; Zhou P; Shao J; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):152-64. PubMed ID: 27493869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
    Ix JH; Isakova T; Larive B; Raphael KL; Raj DS; Cheung AK; Sprague SM; Fried LF; Gassman JJ; Middleton JP; Flessner MF; Block GA; Wolf M
    J Am Soc Nephrol; 2019 Jun; 30(6):1096-1108. PubMed ID: 31085679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FGF23 and Klotho system beyond mineral metabolism.
    Kuro-O M
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):64-69. PubMed ID: 27838783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls.
    Mitchell DM; Jüppner H; Burnett-Bowie SM
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1151-1160. PubMed ID: 28323960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Calciprotein Monomers and Chronic Kidney Disease Progression.
    Tiong MK; Holt SG; Ford ML; Smith ER
    Am J Nephrol; 2022; 53(11-12):806-815. PubMed ID: 36473431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal mitochondrial autophagy in nephropathic cystinosis.
    Sansanwal P; Sarwal MM
    Autophagy; 2010 Oct; 6(7):971-3. PubMed ID: 20729635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.
    Phelps KR; Mason DL; Stote KS
    Clin Nephrol; 2016 May; 85(5):251-61. PubMed ID: 26951967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
    Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
    Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.